Literature DB >> 17199770

Prognosis of stage I pressure ulcers and related factors.

Miwa Sato1, Hiromi Sanada, Chizuko Konya, Junko Sugama, Gojiro Nakagami.   

Abstract

The prognosis of stage I pressure ulcers cannot be predicted; therefore, nursing interventions for preventing their deterioration have not been clearly established. This study describes the clinical course of stage I pressure ulcers and prospectively investigates the factors related to their deterioration. Thirty-one stage I pressure ulcers in 30 patients in a long-term care facility were studied, and morphological changes were assessed every day until the ulcers healed or deteriorated. The physiological changes were assessed by ultrasonography and thermography. Twenty ulcers healed, and 11 deteriorated. The characteristics of deterioration were as follows: (1) double erythema; (2) non blanchable erythema across the whole area determined by glass plate compression; (3) erythema away from the tip of the bony prominence; and (4) expanding erythema on the following day. We analysed the sensitivity, specificity, positive predictive value, negative predictive value and positive likelihood ratio for the diagnostic utility of the indicators of deterioration double erythema and distance from the tip of bony prominence, which can be instantly assessed without the use of any special device. The values were 36.4%, 95.0%, 80.0%, 73.1% and 7.28, respectively. These results suggest that clinicians can predict the prognosis of stage I pressure ulcers by initial assessment and provide appropriate care based on the assessment.

Entities:  

Mesh:

Year:  2006        PMID: 17199770      PMCID: PMC7951350          DOI: 10.1111/j.1742-481X.2006.00267.x

Source DB:  PubMed          Journal:  Int Wound J        ISSN: 1742-4801            Impact factor:   3.315


  14 in total

1.  Shearing force as a factor in decubitus ulcers in paraplegics.

Authors:  S M REICHEL
Journal:  J Am Med Assoc       Date:  1958-02-15

Review 2.  Pressure ulcers prevalence, cost and risk assessment: consensus development conference statement--The National Pressure Ulcer Advisory Panel.

Authors: 
Journal:  Decubitus       Date:  1989-05

Review 3.  Should we include deep tissue injury in pressure ulcer staging systems? The NPUAP debate.

Authors:  J Donnelly
Journal:  J Wound Care       Date:  2005-05       Impact factor: 2.072

Review 4.  Conceptualization of the stage 1 pressure ulcer.

Authors:  C H Lyder
Journal:  J ET Nurs       Date:  1991 Sep-Oct

5.  A quantitative analysis of pressure and shear in the effectiveness of support surfaces.

Authors:  R Fontaine; S Risley; R Castellino
Journal:  J Wound Ostomy Continence Nurs       Date:  1998-09       Impact factor: 1.741

6.  Clinical skin temperature measurement to predict incipient pressure ulcers.

Authors:  S Sprigle; M Linden; D McKenna; K Davis; B Riordan
Journal:  Adv Skin Wound Care       Date:  2001 May-Jun       Impact factor: 2.347

7.  Purple ulcers.

Authors:  J A Witkowski
Journal:  J ET Nurs       Date:  1993 May-Jun

8.  Histopathology of the decubitus ulcer.

Authors:  J A Witkowski; L C Parish
Journal:  J Am Acad Dermatol       Date:  1982-06       Impact factor: 11.527

9.  Intraoperatively acquired pressure ulcer prevalence: a national study.

Authors:  S A Aronovitch
Journal:  J Wound Ostomy Continence Nurs       Date:  1999-05       Impact factor: 1.741

10.  Analysis of localized erythema using clinical indicators and spectroscopy.

Authors:  Stephen Sprigle; Maureen Linden; Brian Riordan
Journal:  Ostomy Wound Manage       Date:  2003-03       Impact factor: 2.629

View more
  9 in total

1.  Changes in serum and exudate creatine phosphokinase concentrations as an indicator of deep tissue injury: a pilot study.

Authors:  Yunita Sari; Gojiro Nakagami; Ai Kinoshita; Lijuan Huang; Kohei Ueda; Shinji Iizaka; Hiromi Sanada; Junko Sugama
Journal:  Int Wound J       Date:  2008-12       Impact factor: 3.315

2.  Establishment of a novel rat model for deep tissue injury deterioration.

Authors:  Yunita Sari; Takeo Minematsu; Lijuan Huang; Hiroshi Noguchi; Taketoshi Mori; Gojiro Nakagami; Takashi Nagase; Makoto Oe; Junko Sugama; Kotaro Yoshimura; Hiromi Sanada
Journal:  Int Wound J       Date:  2013-05-07       Impact factor: 3.315

3.  Wound outcomes in patients with advanced illness.

Authors:  Vincent Maida; Marguerite Ennis; Jason Corban
Journal:  Int Wound J       Date:  2012-02-02       Impact factor: 3.315

4.  HEAT TRANSFER MODEL AND QUANTITATIVE ANALYSIS OF DEEP TISSUE INJURY.

Authors:  Arjun Chanmugam; Akanksha Bhargava; Cila Herman
Journal:  Int Mech Eng Congress Expo       Date:  2012-11

5.  A prospective study of blanchable erythema among university hospital patients.

Authors:  Chie Konishi; Junko Sugama; Hiromi Sanada; Mayumi Okuwa; Chizuko Konya; Tomoe Nishizawa; Kimi Shimamura
Journal:  Int Wound J       Date:  2008-06       Impact factor: 3.315

6.  Predicting the different progressions of early pressure injury by ultraviolet photography in rat models.

Authors:  Huiwen Xu; Yanwei Wang; En Takashi; Akio Kamijo; Daiji Miura; Kunie Karasawa; Akio Kitayama; Jian Lu; Lan Zhang
Journal:  Int Wound J       Date:  2021-09-01       Impact factor: 3.315

7.  Heat transfer model for deep tissue injury: a step towards an early thermographic diagnostic capability.

Authors:  Akanksha Bhargava; Arjun Chanmugam; Cila Herman
Journal:  Diagn Pathol       Date:  2014-02-20       Impact factor: 2.644

8.  Treatment of early-stage pressure ulcers by using autologous adipose tissue grafts.

Authors:  Giovanni Francesco Marangi; Tiziano Pallara; Barbara Cagli; Emiliano Schena; Francesco Giurazza; Elio Faiella; Bruno Beomonte Zobel; Paolo Persichetti
Journal:  Plast Surg Int       Date:  2014-04-10

9.  Biological responses of three-dimensional cultured fibroblasts by sustained compressive loading include apoptosis and survival activity.

Authors:  Toshiki Kanazawa; Gojiro Nakagami; Takeo Minematsu; Takumi Yamane; Lijuan Huang; Yuko Mugita; Hiroshi Noguchi; Taketoshi Mori; Hiromi Sanada
Journal:  PLoS One       Date:  2014-08-07       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.